Abstract
DNA arrays, first described in 1995, were an immediate success and, for a while, represented the only really large-scale technology available for biology. They quickly evolved towards increased complexity, better quality and lower price, thanks largely to industry involvement. In research settings, they were at first essentially used to obtain expression profiles, but their major use today is in genome-wide association studies of complex diseases. Clinical applications fall into two major categories: expression profiling of tumours to predict cancer recurrence and orient treatment, and genotyping (DNA) studies. The latter can be focused on characterisation of pathogenic organisms or, alternatively, on examination of the patient’s DNA to assess for the presence of specific mutations as well as of copy number variations (CNVs) that may have medical significance. These applications are briefly discussed here and then presented in more detail in the following three chapters (expression, genotyping and copy number variation, respectively).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Similar to the devices found in video projectors.
- 2.
In March 2001, the list price, in Europe, for a set of five Affymetrix arrays (U95 A to E) representing the whole human transcriptome (as far as it was known at the time) was €6,400.
- 3.
The breast cancer prognostic tests discussed in Chap. 3 all cost at least €2,000, worthwhile only if their use can lead to avoidance of unnecessary chemotherapy.
- 4.
References
Ashley EA, Butte AJ, Wheeler MT et al (2010) Clinical assessment incorporating a personal genome. Lancet 375:1525–1535
Børresen-Dale AL (2003) Genetic profiling of breast cancer: from molecular portraits to clinical utility. Int J Biol Markers 18:54–56
Chapman P (2010) Global cancer treatment market worth $50 billion. http://www.companiesandmarkets.com/news/global-cancer-treatment-market-worth-50-billion-led-by-mab-brands-mabthera-avastin-and-herceptin-n122.aspx?prk=33f895519277bace25c442b39bd0a1e3. Accessed 1 July 2011
DeRisi JL, Iyer VR (1999) Genomics and array technology. Curr Opin Oncol 11:76–79
Glas AM, Floore A, Delahaye LJ, Witteveen AT et al (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278
Gress TM, Hoheisel JD, Lennon GG, Zehetner G, Lehrach H (1992) Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues. Mamm Genome 3:609–619
Gunderson KL, Steemers FJ, Ren H, Ng P, Zhou L, Tsan C, Chang W, Bullis D, Musmacker J, King C, Lebruska LL, Barker D, Oliphant A, Kuhn KM, Shen R (2006) Whole-genome genotyping. Methods Enzymol 410:359–376
Jain KK (2005) Applications of AmpliChip CYP45. Mol Diagn 9:119–127
Jordan BR (2004) How consistent are gene expression chip platforms? BioEssays 26:1236–1242
Jordan BR (2010) Is there a niche for DNA microarrays in molecular diagnostics? Expert Rev Mol Diagn 10:875–882
Lam CW, Lau KC, Tong SF (2010) Microarrays for personalized genomic medicine. Adv Clin Chem 52:1–18
Lennon GG, Lehrach H (1991) Hybridization analyses of arrayed cDNA libraries. Trends Genet 7:314–317
Lenoir T, Giannella E (2006) The emergence and diffusion of DNA microarray technology. J Biomed Discov Collab 1:11
Li X, Quigg RJ, Zhou J, Gu W, Nagesh Rao P, Reed EF (2008) Clinical utility of microarrays: current status, existing challenges and future outlook. Curr Genomics 9:466–474
MAQC Consortium, Shi et al (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161
Medical News Today (2008) Global molecular diagnostics market to reach 3.67 billion dollars by 2010, according to new report by Global Industry Analysts, Inc. http://www.medicalnewstoday.com/articles/104274.php. Accessed 25 July 2011
Moser M (2001) Analysts predict red hot future for Biochips: sector poised to grow to $3.3 billion by 2004. bioArray News 1:3–4. http://www.genomeweb.com/arrays/analysts-predict-red-hot-future-biochips-sector-poised-grow-33-billion-2004. Accessed 25 July 2011
Nguyen C, Rocha D, Granjeaud S, Baldit M, Bernard K, Naquet P, Jordan BR (1995) Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. Genomics 29:207–215
Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–470
Simon R (2008) Lost in translation: problems and pitfalls in translating laboratory observations to clinical utility. Eur J Cancer 44:2707–2713
Tan PK, Downey TJ, Spitznagel EL Jr, Xu P, Fu D et al (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 31:5676–5684
Zhao N, Hashida H, Takahashi N, Misumi Y, Sakaki Y (1995) High-density cDNA filter analysis: a novel approach for large-scale, quantitative analysis of gene expression. Gene 156:207–213
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jordan, B. (2012). DNA Arrays in Many Guises. In: Jordan, B. (eds) Microarrays in Diagnostics and Biomarker Development. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28203-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-28203-4_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28202-7
Online ISBN: 978-3-642-28203-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)